Adenoma, Islet Cell

Recruiting

Study Name: Laser Tissue Welding - Distal Pancreatectomy Sealing Study
Condition: Pancreatic Tumor, Benign Pancreatic Neoplasms Pancreatic A
Date: 2017-05-08
Interventions: Device: Distal Pancreatectomy Sealing Using LTW The device's intended use is to seal the pancreatic surf

Recruiting

Study Name: Prospective Longitudinal Biomarker Study in Pancreatic Neuroendocrine Tumours
Condition: Neuroendocrine Tumors
Date: 2017-04-06
Interventions: Procedure: Core Needle Biopsy

Recruiting

Study Name: Asymptomatic Small Pancreatic Endocrine Neoplasms.
Condition: Non Functioning Pancreatic Endocrine Tumor
Date: 2017-03-06
Interventions: Diagnostic Test: Radiological imaging studies

Recruiting

Study Name: Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET)
Condition: Multiple Endocrine Neoplasia Pancreatic Neuroendocrine Tumors
Date: 2017-02-13
Interventions: Other: Genome Sequencing Analy

Not yet recruiting

Study Name: Pasireotide in Hyperinsulinemic Hypoglycemia
Condition: Congenital Hyperinsulinism Insulinoma Hyperinsulinism
Date: 2017-02-09
Interventions: Drug: Pasireotide 0.6Mg Solution for Injection

Recruiting

Study Name: Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients
Condition: Multiple Endocrine Neoplasia
Date: 2017-02-07

Recruiting

Study Name: Overall and Disease Specific Survival in Patients With Confirmed MEN1 With or Without PNET (Pancreatic Neuroendocrine Tumors)
Condition: Genetic Mutation MEN1
Date: 2017-02-02
Interventions: Other: Chart Review Database r

Not yet recruiting

Study Name: Everolimus TDM to Predict Long Term Toxicity
Condition: Breast Cancer Renal Cell Carcinoma Pancreatic Neuroendocri
Date: 2017-01-24

Not yet recruiting

Study Name: Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs
Condition: Neuroendocrine Tumors Neoplasms Cancer
Date: 2016-10-21
Interventions: Drug: TAS-102 Anti-metabolite

Recruiting

Study Name: Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery
Condition: Pancreatic Neuroendocrine Tumor G1 Pancreatic Neuroendocrine Tumor G2
Date: 2016-09-08
Interventions: Drug: Sapanisertib Given PO Other Names:

A Network Connecting Health Care Professionals
Connecting Millions Of MDs, Hospitals and Clinics

sign up

log in

Adenoma, Islet Cell - 110 Studies Found

Status	Study
Recruiting	Study Name: Laser Tissue Welding - Distal Pancreatectomy Sealing Study Condition: Pancreatic Tumor, Benign Pancreatic Neoplasms Pancreatic A Date: 2017-05-08 Interventions: Device: Distal Pancreatectomy Sealing Using LTW The device's intended use is to seal the pancreatic surf
Recruiting	Study Name: Prospective Longitudinal Biomarker Study in Pancreatic Neuroendocrine Tumours Condition: Neuroendocrine Tumors Date: 2017-04-06 Interventions: Procedure: Core Needle Biopsy
Recruiting	Study Name: Asymptomatic Small Pancreatic Endocrine Neoplasms. Condition: Non Functioning Pancreatic Endocrine Tumor Date: 2017-03-06 Interventions: Diagnostic Test: Radiological imaging studies
Recruiting	Study Name: Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET) Condition: Multiple Endocrine Neoplasia Pancreatic Neuroendocrine Tumors Date: 2017-02-13 Interventions: Other: Genome Sequencing Analy
Not yet recruiting	Study Name: Pasireotide in Hyperinsulinemic Hypoglycemia Condition: Congenital Hyperinsulinism Insulinoma Hyperinsulinism Date: 2017-02-09 Interventions: Drug: Pasireotide 0.6Mg Solution for Injection
Recruiting	Study Name: Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients Condition: Multiple Endocrine Neoplasia Date: 2017-02-07
Recruiting	Study Name: Overall and Disease Specific Survival in Patients With Confirmed MEN1 With or Without PNET (Pancreatic Neuroendocrine Tumors) Condition: Genetic Mutation MEN1 Date: 2017-02-02 Interventions: Other: Chart Review Database r
Not yet recruiting	Study Name: Everolimus TDM to Predict Long Term Toxicity Condition: Breast Cancer Renal Cell Carcinoma Pancreatic Neuroendocri Date: 2017-01-24
Not yet recruiting	Study Name: Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs Condition: Neuroendocrine Tumors Neoplasms Cancer Date: 2016-10-21 Interventions: Drug: TAS-102 Anti-metabolite
Recruiting	Study Name: Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery Condition: Pancreatic Neuroendocrine Tumor G1 Pancreatic Neuroendocrine Tumor G2 Date: 2016-09-08 Interventions: Drug: Sapanisertib Given PO Other Names: